Invention Grant
- Patent Title: Tumor-infiltrating lymphocytes for adoptive cell therapy
-
Application No.: US16272524Application Date: 2019-02-11
-
Publication No.: US11518980B2Publication Date: 2022-12-06
- Inventor: Amod A. Sarnaik , Shari Pilon-Thomas , Mark McLaughlin , Hao Liu
- Applicant: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. , UNIVERSITY OF SOUTH FLORIDA
- Applicant Address: US FL Tampa; US FL Tampa
- Assignee: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.,UNIVERSITY OF SOUTH FLORIDA
- Current Assignee: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.,UNIVERSITY OF SOUTH FLORIDA
- Current Assignee Address: US FL Tampa; US FL Tampa
- Agency: Meunier Carlin & Curfman LLC
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; A61K39/00 ; A61K35/12 ; G01N33/50
Abstract:
Disclosed are compositions and methods for ex vivo expansion of tumor-infiltrating lymphocytes for use in adoptive cell therapy (ACT). Also disclosed are compositions and method for identifying an agent for ex vivo expansion of tumor-infiltrating lymphocytes for use in ACT. Also disclosed are methods for treating cancer using tumor-infiltrating lymphocytes expanded by the disclosed methods.
Public/Granted literature
- US20190177693A1 TUMOR-INFILTRATING LYMPHOCYTES FOR ADOPTIVE CELL THERAPY Public/Granted day:2019-06-13
Information query
